Get a glimpse into our company and investor data—powered by the PitchBook Platform
Operator of a clinical research organization. The company focuses on the discovery and development of new products and treatments with stem cells derived from adult patients' own fat cells, known as autologous derived stem cells to help patients with various chronic and acute medical conditions.
You’re viewing a free company profile from the PitchBook Platform. To explore Antria’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Angel (individual) | 30-Jul-2015 | Cancelled | Startup | |||
1. Angel (individual) | 24-Jan-2013 | 00.000 | 00.000 | Completed | Startup |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
David Bizousky MD | Antria | Medical Monitor & Board Member | 000 0000 | |
Leonard Maliver MD | Antria | Chief Executive Officer & Board Member | 000 0000 | |
Shah Rahimian MD | Antria | President, Research & Development & Board Member | 000 0000 | |
Sharon Barto | Antria | Vice President, Business Development & Board Member | 000 0000 |